AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Precipio, Inc. Director's Dealing 2014

Feb 20, 2014

34807_dirs_2014-02-20_8ce412bc-5a80-466a-b070-84babbaa0ff3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO.OB)
CIK: 0001043961
Period of Report: 2014-02-18

Reporting Person: Kinnon Paul (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-18	Purchase Option	$5.54	A	6667	Acquired	2024-02-17	Common Stock (6667)	Direct
2014-02-18	Purchase Option	$5.54	A	6667	Acquired	2024-02-17	Common Stock (6667)	Direct
2014-02-18	Purchase Option	$5.54	A	6666	Acquired	2024-02-17	Common Stock (6666)	Direct

Footnotes

F1: Common Stock, par value $.01 per share of Transgenomic, Inc.

F2: The various numbers listed in Columns 5, 7 and 9 relate to a single option grant which entitles the reporting person to purchase up to an aggregate of 20,000 shares of Common Stock, par value $.01 per share of Transgenomic, Inc.